Apatinib is effective for treatment of advanced hepatocellular carcinoma

As treatment options for hepatocellular carcinoma (HCC) are currently limited, we evaluated the efficacy and safety of oral apatinib, a VEGFR-2 inhibitor, on patients with advanced HCC. Twenty-two patients from Tianjin Medical University Cancer Institute and Hospital were enrolled for evaluation. Ap...

Descripción completa

Detalles Bibliográficos
Autores principales: Kong, Yinlong, Sun, Lin, Hou, Zhenyu, Zhang, Yongqiang, Chen, Ping, Cui, Yunlong, Zhu, Xiaolin, Song, Tianqiang, Li, Qiang, Li, Huikai, Zhang, Ti, Qin, Lunxiu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2017
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5739662/
https://www.ncbi.nlm.nih.gov/pubmed/29285275
http://dx.doi.org/10.18632/oncotarget.22337

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5739662/
https://www.ncbi.nlm.nih.gov/pubmed/29285275
http://dx.doi.org/10.18632/oncotarget.22337

Ejemplares similares